Lionco Pharmaceutical Group Co.,Ltd. (603669.SS)
CNY 6.69
(-3.04%)
CNY 6.69
(-3.04%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.62 Billion CNY | -12.44% |
| 2022 | 1.85 Billion CNY | -26.21% |
| 2021 | 2.51 Billion CNY | -7.43% |
| 2020 | 2.71 Billion CNY | 41.95% |
| 2019 | 1.91 Billion CNY | -7.47% |
| 2018 | 2.06 Billion CNY | 25.2% |
| 2017 | 1.65 Billion CNY | 22.89% |
| 2016 | 1.34 Billion CNY | 0.04% |
| 2015 | 1.34 Billion CNY | 139.98% |
| 2014 | 559.83 Million CNY | -3.83% |
| 2013 | 582.11 Million CNY | 59.53% |
| 2012 | 364.89 Million CNY | 49.31% |
| 2011 | 244.38 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.2 Billion CNY | -16.74% |
| 2024 Q1 | 1.48 Billion CNY | -8.7% |
| 2024 Q2 | 1.44 Billion CNY | -2.37% |
| 2023 Q4 | 1.62 Billion CNY | -9.9% |
| 2023 FY | 1.62 Billion CNY | -12.44% |
| 2023 Q3 | 1.8 Billion CNY | 0.3% |
| 2023 Q1 | 1.9 Billion CNY | 2.83% |
| 2023 Q2 | 1.79 Billion CNY | -5.78% |
| 2022 Q4 | 1.85 Billion CNY | -1.43% |
| 2022 Q2 | 2.16 Billion CNY | -12.28% |
| 2022 FY | 1.85 Billion CNY | -26.21% |
| 2022 Q3 | 1.88 Billion CNY | -12.91% |
| 2022 Q1 | 2.46 Billion CNY | -2.0% |
| 2021 Q1 | 2.75 Billion CNY | 1.27% |
| 2021 Q3 | 2.69 Billion CNY | -2.69% |
| 2021 FY | 2.51 Billion CNY | -7.43% |
| 2021 Q4 | 2.51 Billion CNY | -6.73% |
| 2021 Q2 | 2.77 Billion CNY | 0.71% |
| 2020 FY | 2.71 Billion CNY | 41.95% |
| 2020 Q1 | 2.02 Billion CNY | 5.67% |
| 2020 Q2 | 1.92 Billion CNY | -5.03% |
| 2020 Q3 | 2.05 Billion CNY | 7.03% |
| 2020 Q4 | 2.71 Billion CNY | 32.16% |
| 2019 FY | 1.91 Billion CNY | -7.47% |
| 2019 Q3 | 2.1 Billion CNY | 6.02% |
| 2019 Q4 | 1.91 Billion CNY | -9.18% |
| 2019 Q2 | 1.98 Billion CNY | -1.21% |
| 2019 Q1 | 2.01 Billion CNY | -2.74% |
| 2018 Q1 | 1.66 Billion CNY | 0.81% |
| 2018 FY | 2.06 Billion CNY | 25.2% |
| 2018 Q4 | 2.06 Billion CNY | 20.82% |
| 2018 Q3 | 1.71 Billion CNY | 0.85% |
| 2018 Q2 | 1.69 Billion CNY | 1.92% |
| 2017 Q2 | 1.41 Billion CNY | 5.54% |
| 2017 FY | 1.65 Billion CNY | 22.89% |
| 2017 Q1 | 1.34 Billion CNY | -0.11% |
| 2017 Q4 | 1.65 Billion CNY | 10.98% |
| 2017 Q3 | 1.48 Billion CNY | 5.04% |
| 2016 Q2 | 1.29 Billion CNY | -1.56% |
| 2016 Q4 | 1.34 Billion CNY | 6.87% |
| 2016 Q3 | 1.25 Billion CNY | -2.6% |
| 2016 Q1 | 1.31 Billion CNY | -2.37% |
| 2016 FY | 1.34 Billion CNY | 0.04% |
| 2015 Q4 | 1.34 Billion CNY | 4.17% |
| 2015 FY | 1.34 Billion CNY | 139.98% |
| 2015 Q3 | 1.28 Billion CNY | 0.47% |
| 2015 Q2 | 1.28 Billion CNY | 96.56% |
| 2015 Q1 | 653.08 Million CNY | 16.66% |
| 2014 Q4 | 559.83 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | 559.83 Million CNY | -3.83% |
| 2013 FY | 582.11 Million CNY | 59.53% |
| 2012 FY | 364.89 Million CNY | 49.31% |
| 2011 FY | 244.38 Million CNY | 0.0% |